Suppr超能文献

一氧化氮:重症监护领域的一个新方向。

Nitric oxide: a new area in intensive care.

作者信息

Rossaint R

机构信息

Klinik für Anaesthesiologie und operative Intensivmedizin, Freie Universität Berlin, Universitätsklinikum Rudolf Virchow, Germany.

出版信息

Presse Med. 1994 May 14;23(18):855-8.

PMID:7937607
Abstract

The relaxing effects of nitric oxide on smooth muscles, first identified in 1987, inaugurated a new area of therapeutic efficacity in intensive care. Nitric oxide is synthesized by endothelial cells, macrophages, brain cells and other cells following immunological activation and plays a role in normal blood pressure homeostasis, neuromodulation, cytotoxicity and intracellular message transmission. Since inappropriate vasodilatation or shock may result from cytokine- or endotoxin-induced overproduction of nitric oxide, experiments have been conducted on the effect of nitric oxide synthase inhibitors on shock-induced hypotension. In animal models, results have demonstrated a new method for treating septic shock since infusing nitric oxide inhibitors can rapidly re-establish haemodynamics. Nevertheless, due to possible interference with the immune defense system further studies on the physiological, pharmacological and metabolic effects are required before routine antishock therapy can be used in the intensive care unit. Inversely, in pulmonary hypertension there may be an insufficient production of endogenous nitric oxide. Thus administration via inhalation would represent a promising replacement therapy. In addition, since nitric oxide is rapidly inactivated by haemoglobin, its vasodilatory effect is restricted to the pulmonary vasculature resulting in lowered pulmonary artery pressure without systemic vasodilatation. Effective protocols have been developed for primary pulmonary hypertension of the newborn and acute respiratory distress syndrome. The bronchodilatory effect of nitric oxide is another area suggesting an alternative approach to treating different causes of bronchoconstriction including asthma. The results of early clinical trials are awaited. When used in low concentrations under continuous monitoring, nitric oxide is a safe new therapeutic option for the treatment of pulmonary hypertension and nitric oxide inhibitors may have an important role to play in the management of septic shock.

摘要

一氧化氮对平滑肌的舒张作用于1987年首次被发现,开创了重症监护治疗效果的新领域。一氧化氮由内皮细胞、巨噬细胞、脑细胞和其他免疫激活后的细胞合成,在正常血压稳态、神经调节、细胞毒性和细胞内信息传递中发挥作用。由于细胞因子或内毒素诱导的一氧化氮过量产生可能导致不适当的血管舒张或休克,因此已经进行了关于一氧化氮合酶抑制剂对休克诱导的低血压影响的实验。在动物模型中,结果表明了一种治疗感染性休克的新方法,因为输注一氧化氮抑制剂可以迅速恢复血流动力学。然而,由于可能干扰免疫防御系统,在重症监护病房常规使用抗休克治疗之前,还需要对其生理、药理和代谢作用进行进一步研究。相反,在肺动脉高压中,内源性一氧化氮的产生可能不足。因此,通过吸入给药将是一种有前景的替代疗法。此外,由于一氧化氮会迅速被血红蛋白灭活,其血管舒张作用仅限于肺血管系统,从而在不引起全身血管舒张的情况下降低肺动脉压。已经为新生儿原发性肺动脉高压和急性呼吸窘迫综合征制定了有效的方案。一氧化氮的支气管舒张作用是另一个领域,提示了一种治疗包括哮喘在内的不同原因支气管收缩的替代方法。早期临床试验的结果值得期待。在持续监测下以低浓度使用时,一氧化氮是治疗肺动脉高压的一种安全的新治疗选择,一氧化氮抑制剂可能在感染性休克的治疗中发挥重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验